Moving Precision Medicine Forward
DNA analysis at speed and scale
Dedicated bioinformatics support
Today's conventional technology for measuring cellular mutations and heterogeneity for complex disease is bulk sequencing based on averages. However, the problem with averages is that the underlying genetic diversity is missed across cell populations. Understanding this diversity is important for patient stratification, therapy selection, and disease monitoring. Moving beyond averages helps to deliver on the promise of precision medicine.
The current one-size-fits-all approach of medical treatments isn’t working for many patients who need help. To move precision medicine forward, researchers and clinicians need to look at the origins of disease — the single cell — in meaningful new ways.
Because most diseases are not caused by just one mutation, understanding genetic variability — including mutation co-occurrence at the single-cell level — is vitally important for clinical researchers. However, this level of resolution is missed with existing bulk sequencing which can result in failed clinical trials, high costs, and poor patient outcomes.
To impact precision drug discovery, development, and delivery, we need insight into the mutational differences with and among every single cell.
The Mission Bio site works on all modern browsers with legacy support back through Internet Explorer 9. Please update by going to the link below.Update Browser